Optiscan has been featured in The Australian and Stockhead, highlighting its innovative approach to addressing the global shortage of pathologists through its advanced digital pathology technology. The World Health Organization estimates a shortfall of 10 million health workers by 2030, with significant impacts on healthcare delivery.

The article emphasizes how Optiscan's pioneering slide-free and biopsy-free technology enables real-time cancer diagnostics, streamlining the workflow for pathologists. CEO Dr. Camile Farah noted that this technology can reduce bottlenecks in pathology testing, allowing for quicker and more efficient diagnoses. Furthermore, the integration of AI algorithms aims to assist clinicians and pathologists, enhancing diagnostic accuracy.

As healthcare systems face increasing pressures, Optiscan's solutions are positioned to play a critical role in improving efficiency and outcomes in medical diagnostics.

The Australian - Read the full article here.

 

Stockhead - Read the full article here.